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Abstract
The trans-apical aortic valve implantation (TA-AVI) is an established technique for high-risk patients requiring aortic valve replacement.
Traditionally, preoperative (computed tomography (CT) scan, coronary angiogram) and intra-operative imaging (fluoroscopy) for stent-valve
positioning and implantation require contrast medium injections. To preserve the renal function in elderly patients suffering from chronic
renal insufficiency, a fully echo-guided trans-catheter valve implantation seems to be a reasonable alternative. We report the first
successful TA-AVI procedure performed solely under trans-oesophageal echocardiogram control, in the absence of contrast medium
injections.
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The trans-apical aortic valve implantation (TA-AVI) is a
valid technique for aortic valve replacement (AVR) in high-
risk patients. The stent-valve positioning and implantation
are normally based on landmarks (annulus diameter, pattern
of calcifications, distance between the annulus and the
coronary ostia, coronary anomalies) preoperatively identi-
fied by a cardiac computed tomography (CT) scan and a
coronary angiogram, and confirmed intra-operatively by
fluoroscopy with contrast medium injections [1]. Unfortu-
nately, following extensive use of contrast medium, patients
selected for trans-catheter AVR and suffering from chronic
renal insufficiency are exposed to a higher risk of acute
postoperative renal failure [2]. Consequently, we believe
that the quantity of contrast medium administered intra-
operatively should be decreased or completely avoided:
following our experience on endovascular aorta repair
without contrast medium [3,4], we identified a valid
alternative in the fully echo-guided trans-catheter valve
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Centre Hoˆpitalier Universitaire Vaudois (CHUV), 46 Rue du Bugnon, CH-1011
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An 82-year-old female patient suffered from severe
respiratory disease, coronary artery disease (stent in the left
anterior descending (LAD)), diabetes, hypertension, periph-
eral vascular disease and chronic renal insufficiency (pre-
operative creatinine level of 170 mg dl1). She was also
suffering from a severe and symptomatic aortic valve stenosis
(aortic orifice area of 0.43 cm2 m2), with moderate left
ventricular hypertrophy, good left ventricular function (ejec-
tion fraction of 60%) and pulmonary hypertension (systolic
pulmonary pressure of 55 mmHg). The logistic EuroSCORE was
42% and the patient accepted a TA-AVI procedure. To identify
the landmarks and to calculate the perspective of the aortic
valve plane for the C-arm fluoroscopy orientation (108 caudal
and 108 left, as shown in Fig. 1), a cardiac CT scan with a low
dose of contrast medium (50 ml) was performed: no coronary
anomalies were found and the distance between the aortic
annulus and the coronary ostia was 10.5 mm left and 11 mm
right, respectively. The calculated aortic annulus diameter
was 23.5 mm. Under general anaesthesia and in the operative
theatre, the patient underwent a TA-AVI procedure: the guide-
wires in the femoral vessels (CPB stand-by), the left mini-
thoracotomy and two reinforced 2/0 prolene purse-string
sutures in the apex were prepared in the standard way. After
heparinisation (100 U kg1), a pig-tail catheter was placed in
the ascending aorta (kept ready for contrast mediumurgery. Published by Elsevier B.V. All rights reserved.
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Fig. 1. (A) Selective three-dimensional aortic root reconstruction from the
preoperative cardiac CT-scan: the perspective of the aortic valve plane is
identified and measured as number of degrees in cranio-caudal and lateral
orientation. The procedure is helpful to orientate the C-arm fluoroscopy in the
operative room (in this case: 108 caudal and 108 on the left). (B) A picture taken
from the C-arm fluoroscopy after the stent-valve deployment: the optimal
preoperative C-arm fluoroscopy orientation is confirmed by the stent-valve
plane.
Fig. 2. The sequence shows the full echo-guided trans-apical valve implanta-
tion. (A) Aortic valvuloplasty; (B) stent-valve ballooning; (C) balloon deflation;
(D) sapien stent-valve in place.injection, if necessary) and guide-wires were inserted through
the apex and towards the aortic valve, under C-arm
fluoroscopy and trans-oesophageal echocardiogram (TEE
control). The two-dimensional TEE (2D-TEE) measurements
confirmed the annulus diameter (23 mm) and landmarks
(specifically with regard to the coronary ostia and the aortic
annulus position). The valvuloplasty was performed under
direct TEE-guidedballoon positioning plusfluoroscopy control,
and, successively, a 26-mm Sapien stent valve (Edwards
Lifesciences Inc., Irvine, CA, USA) was implanted under fullyTEE-guided valve positioning and simultaneous fluoroscopy
control (Fig. 2). The 2D-TEE confirmed the correct valve
placement with a peak gradient of 6 mmHg and absence of
paravalvular leakage. Postoperatively, the recovery was
uneventful with a fast-track extubation and 2 days in the
intensive care unit. The postoperative serum creatinine level
did not increase (153 mg dl1 at day 1 and 145 mg dl1 at day 2)
and a pre-discharge echocardiogram (day 8) showed an aortic
peak and mean gradient of 12 mmHg and 7.5 mmHg,
respectively, without paravalvular leakage.
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The fully echo-guided TA-VI seems a valid alternative to the
standard TA-VI procedure: the recent published reports have
shownan incidenceofpostoperative renal failure reaching 28%
followed, sometimes, by transitory or permanent dialysis [2].
This severe complication is reasonably due to the impaired
preoperative renal function coupled with an extensive use of
contrast medium: the average of contrast injected during a
standard TAVI procedure is around 100—300 ml [5,6], and the
total amount increases rapidly when we take into considera-
tion the doses necessary for the preoperative CTscan and the
coronary angiogram. In order to diminish the risk of renal
failure, we recommend a fully echo-guided TA-AVI without
contrast medium: the landmarks identification, the balloon
positioning and the stent-valve implantation can be easily
performed with a 2D-TEE (3D-TEE is under evaluation) and the
fluoroscopy remains essential for guide-wire placement,
valvuloplasty control, and stent-valve deployment [7]. This
first case report confirms that this technique allows TA-VI
procedures in intubated high-risk patients and empathise the
role of the intra-operative 2D-TEE as well as the role of
specialised doctors performing it (anaesthetists or cardiolo-
gists). Limitations to this procedure are the presence of
artefacts in the TEE images (concomitant mechanical heart
valve prosthesis in mitral position) and low-quality preopera-
tive CT scans (i.e., presence of cardiac arrhythmias). There-
fore, further reports are required to finalise this technique.References
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